CRGO affiliate sales disclosed in Form 144

CRGO affiliate reported multiple sales of Ordinary shares via Form 144.

Rhea-AI Filing Summary

CRGO affiliate reported multiple sales of Ordinary shares via Form 144. The filing lists repeated dispositions by Zvi Schreiber across March–April 2026, including sales of 10,000 shares on 04/15/2026 for $18,500.00 and 10,000 shares on 04/13/2026 for $16,200.00. The entries appear as routine affiliate sales under compensation-related restricted stock vesting and resale reporting.

Insights

Insider Transactions Analyst

Multiple small-to-moderate affiliate sales recorded; routine reporting.

The filing lists repeated sales by Zvi Schreiber of Ordinary shares on specific dates in March–April 2026, with individual trades shown (for example, 10,000 shares at $18,500.00 on 04/15/2026 and 10,000 shares at $16,200.00 on 04/13/2026). These are presented as dispositions tied to restricted stock vesting and related resale activity.

Cash flow recipients and any trading-plan context are not stated in the excerpt; subsequent filings or broker records would specify proceeds handling. Absent larger position context or unusual timing, this pattern reads as routine affiliate liquidity rather than a clear change to company fundamentals.

Key Figures

Sale on 04/15/2026: 10,000 shares Sale on 04/13/2026: 10,000 shares Sale on 04/08/2026: 10,000 shares +3 more

6 metrics

Sale on 04/15/2026 10,000 shares disposed for $18,500.00 on 04/15/2026

Sale on 04/13/2026 10,000 shares disposed for $16,200.00 on 04/13/2026

Sale on 04/08/2026 10,000 shares disposed for $16,900.00 on 04/08/2026

Sale on 04/01/2026 5,000 shares disposed for $8,200.00 on 04/01/2026

Sale on 03/30/2026 5,000 shares disposed for $8,150.00 on 03/30/2026

Restricted stock line 10,000 shares Restricted stock vesting under a registered plan dated 01/01/2012

Key Terms

Form 144, Restricted stock vesting, Filer Information

3 terms

Form 144 regulatory

"lists multiple sales by Zvi Schreiber across March–April 2026"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted stock vesting financial

"Restricted stock vesting under a registered plan dated 01/01/2012"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Filer Information regulatory

"Filer Information | Issuer Information | Securities Information"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CRGO Form 144 disclose about insider sales?

The Form 144 discloses multiple sales by affiliate Zvi Schreiber in March–April 2026. The entries list specific dates, share counts, and gross proceeds for each transaction, showing several 10,000-share and 5,000-share dispositions.

How many shares did the affiliate sell in specific CRGO entries?

The excerpt shows individual trades of 10,000 and 5,000 Ordinary shares. Examples include 10,000 shares on 04/15/2026 and 5,000 shares on 04/01/2026, each with an associated dollar amount.

Were the CRGO sales linked to restricted stock vesting?

Yes. The filing notes a line for Restricted stock vesting under a registered plan dated 01/01/2012, indicating at least some dispositions relate to compensation-derived shares becoming tradable under resale rules.

Does the Form 144 state who received the sale proceeds for CRGO?

The excerpt does not specify the recipient of sale proceeds. The entries list gross proceeds for each trade, but the filing text provided does not state whether proceeds go to the issuer or selling holder.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 04:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001976454
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FREIGHTOS LIMITED
SEC File Number	001-41604
Address of Issuer	PLANTA 10, AVDA. DIAGONA BARCELONA SPAIN 08018
Phone	34 933 79 93 01
Name of Person for Whose Account the Securities are To Be Sold	ZVI SCHREIBER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	21300.00	51376890	04/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/01/2012	Restricted stock vesting under a registered plan	Issuer			10000	01/01/2012	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/15/2026	10000	18500.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/13/2026	10000	16200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/08/2026	10000	16900.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/01/2026	5000	8200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/30/2026	5000	8150.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/24/2026	10000	15850.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/17/2026	10000	16508.50
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/16/2026	10000	15214.04
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/11/2026	5000	6300.00

144: Remarks and Signature

Remarks
Date of Notice	04/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Zvi Schreiber
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)